Cancer and Molecular and Cellular Biology PGDip
| Program start date | Application deadline |
| 2023-09-19 | 2023-08-01 |
| 2024-01-09 | 2023-12-01 |
| 2024-09-20 | - |
Program Overview
This Postgraduate Diploma in Cancer and Molecular and Cellular Biology offers a comprehensive understanding of cancer's molecular and cellular basis. It equips graduates with skills for academic research or careers in clinical, pharmaceutical, or diagnostic settings. The program covers topics such as cancer biology, pharmacology, drug development, and cancer therapeutics. Students can choose elective modules to specialize in areas like pediatric oncology or cancer prevention and control.
Program Outline
- To equip graduates with the necessary skills and knowledge to pursue further academic or professional careers in cancer research.
- To develop critical thinking and problem-solving skills in the context of cancer research.
- To introduce students to the latest advances in cancer research and treatment.
- To provide opportunities for students to gain practical experience in a research laboratory setting.
Outline
Programme Content
This programme is delivered by the Barts Cancer Institute, a Cancer Research UK centre of excellence and part of the Cancer Research UK City of London Centre.
The programme covers a wide range of topics, including:
- The molecular basis of cancer
- Cancer cell biology
- Cancer genetics
- Cancer immunology
- Cancer therapeutics
- Cancer epidemiology and prevention
- Cancer clinical trials
The programme is structured as follows:
- Eight compulsory modules
- Choice of elective modules
Modules:
#Compulsory Modules:
- Cancer Biology
- Cancer Pharmacology
- Drug Development
- Biological Therapies
- Molecular Diagnostics and Therapeutics
- Research Methods
- Research Lab Skills
- Genomic Approaches to Cancer
- #Elective Modules (choice of two):
- Paediatric and Adolescent Oncology
- Pathology of Cancer and Imaging
- Advanced Topics in Cancer Biology
- Cancer Prevention and Control
- Cancer Informatics
Assessment
Assessment will be based on written assignments and posters and oral presentations. Examinations will be in the form of online assessments which may consist of timed essay questions, short answer questions or case studies.
Teaching
You’ll be taught through a variety of teaching methods including seminars, laboratory practice sessions, self-directed learning, one-to-one tutorials, case presentations, and reading lists of books and journal papers. We take pride in the close and friendly working relationship we have with our students. You’ll be assigned an Academic Mentor, who will guide you in both academic and pastoral matters throughout your time at Queen Mary. If you study part-time, the modules you’ll need to complete the programme will be spread over two years.
Careers
You’ll leave this programme with the clinical skills and experience necessary to pursue further academic research at MSc level.
- This course will start in September 2024.
- This course is available both full-time and part-time.
- The course duration is nine months for full-time students and 21 months for part-time students.
- The fees are £8450 (UK) / £19300 (EU/EEA/Swiss) for full-time students.
- The fees are £4250 (UK) / £9650 (EU/EEA/Swiss) for part-time students.
- The application deadline is July 31, 2024.
Summary:
This PGDip provides a comprehensive overview of the molecular and cellular basis of cancer. You will gain valuable knowledge and skills in cancer biology, pathology, pharmacology and drug development. The course is suitable for those wishing to pursue further academic research or seek career paths in clinical, pharmaceutical or diagnostic settings.
Home: £8,450 Overseas: £19,300 EU/EEA/Swiss studentsThe course fee is charged per annum for 2 years.
Entry Requirements:
A 2:1 or above at undergraduate level in a relevant subject such as Biology, Chemistry, Pharmacology, Medicine from a recognised academic institution.
